3B BlackBio Dx Ltd — Updates, 09-04-2025: Company Update

3B BlackBio Dx Limited has announced a board meeting on financial results for the quarter and half-year ended 31st March 2025. The company clarified that it did not raise any funds through public, rights, or preferential issues during this period, thus a Statement of Deviation or Variation is not applicable. This indicates financial stability without the need for external funding sources. Investors may view this as a neutral impact, reflecting a focused strategy on organic growth and operational efficiency.